Legislative and Regulatory Infrastructure Working Group

In most countries, national legislation is often not equipped to deal with the extremely serious health consequences of counterfeit medical products and penalties for counterfeiters are too light to act as deterrents.
Stronger legislation clearly identifying counterfeiting medical products as a crime will help to empower police, customs officials and the judiciary to better fight this crime.
The Legislative and Regulatory Infrastructure Working Group aims to:

  • survey existing national and international legislation & requirements;
  • assess gaps in existing national and international legislation & requirements on manufacturing, distribution, exportation, and importation;
  • develop model legislation;
  • develop initiatives aimed at law-makers in order to promote adoption of new legislation
  • requirements for the distribution system
  • assess existing national best practices and develop model best practices

Resources

For comments:
Useful links
Share

Contact details

Chair Legislative and Regulatory Infrastructure Working group:
Dr Konstantin Keller,
Federal Ministry of Health, Germany